Twist Bioscience
TWST
Twist Bioscience (TWST) - Cash on Hand
Cash on Hand as of March 2024 : $0.29 B
According to Twist Bioscience
's latest financial reports the company has $0.29 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Twist Bioscience - Cash on Hand chart (from 2017 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-09-30 | $0.33 B | -33.38% |
| 2022-09-30 | $0.50 B | 5.67% |
| 2021-09-30 | $0.47 B | 64.78% |
| 2020-09-30 | $0.29 B | 109.98% |
| 2019-09-30 | $0.13 B | 71.02% |
| 2018-09-30 | $80.75 M | 29.83% |
| 2017-09-30 | $62.2 M | 11.24% |
| 2016-09-30 | $55.92 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $5.29 M | -98.19% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.12 B | -57.25% | 🇬🇧 UK |
 Novavax NVAX | $0.56 B | 93.80% | 🇺🇸 USA |
 Novocure
NVCR | $0.87 B | 196.63% | Jersey |